Select Medical Holdings Corporation (SEM) receives a strong valuation ranking of 73 from InvestorsObserver data analysis. The proprietary ranking system focuses on the underlying health of a company through analysis of its stock price, earnings, and growth rate. SEM has a better value than 73% of stocks based on these valuation analytics. Investors primarily focused on buy-and-hold strategies will find the valuation ranking relevant to their goals when making investment decisions.
SEM gets a 73 Valuation Rank today. Find out what this means to you and get the rest of the rankings on SEM!
SEM's trailing-12-month Price to Earnings (PE) ratio of 8.8 puts it below the historical average of roughly 15. SEM is a good value at its current trading price as investors are paying less than what its worth in relation to the company's earnings. SEM's trailing-12-month earnings per share (EPS) of 2.53 does justify what it is currently trading at in the market. Trailing PE ratios, however, do not factor in a company's projected growth rate, resulting in some firms having high PE ratios due to high growth potentially enticing investors even if current earnings are low.
SEM's 12-month-forward PE to Growth (PEG) ratio of 0.7 is considered a good value as the market is undervaluing SEM in relation to the company's projected earnings growth. SEM's PEG comes from its forward price to earnings ratio being divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. Due to their incorporation of more fundamentals of a company's overall health and focusing on the future rather than the past, PEG ratios are one of the most used valuation metrics by analysts today.
